Health
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%)
· higher is better · 98 countries
United Nations Statistics Division, SDG Global DatabaseUN Terms of Use — non-commercial (SDG Global Database); redistribution deferred pending clearanceupdated 2022
Related rankingsDM_BRTSDM_BRTS_SURVIVING_1DM_DPR_CHDDM_DPR_OLDDM_DPR_TOTDM_FRATE_TOTDM_LIFE_EXPDM_NET_MG_RATEDM_POP_15TO24DM_POP_ADLCNTDM_POP_GRTDM_POP_TOT
League table
85 shown- 1Yemen, Rep.93.5
- 2Zambia90
- 3Bangladesh88.5
- 3Congo, Dem. Rep.88.5
- 4Iraq87.8
- 5Nepal83.3
- 6Cambodia81.3
- 7Jordan76.3
- 8Cameroon76
- 9Egypt, Arab Rep.69.4
- 10Ghana67.9
- 11Pakistan67.1
- 12Myanmar66.7
- 13Papua New Guinea65.5
- 14Nigeria65.1
- 15Ethiopia61.8
- 16Tanzania59.5
- 17Kosovo59.3
- 18Kuwait59.1
- 19Cyprus55.9
- 20Lao PDR55.9
- 21India54.9
- 22North Macedonia53.8
- 22Croatia53.8
- 23Benin52.6
- 24Lebanon52.5
- 25Saudi Arabia52
- 26Sri Lanka51.3
- 27Peru49.2
- 28Hong Kong SAR, China45.8
- 29Korea, Rep.45.7
- 30Colombia45.2
- 31Philippines44.4
- 32Bahrain42.1
- 33Greece41.1
- 34United Arab Emirates39.9
- 35Mauritius39.4
- 36Timor-Leste38.1
- 37Eswatini36.4
- 38Singapore35.7
- 39Indonesia35.2
- 40Iran, Islamic Rep.34.7
- 41Japan33.9
- 42Argentina32.8
- 43Brazil31.6
- 44Turkiye31.4
- 45Italy30.6
- 46Burkina Faso30.4
- 47Qatar30.1
- 48Syrian Arab Republic29.4
- 49Oman28.6
- 50Georgia28.3
- 51Bosnia and Herzegovina26.5
- 52Moldova23.8
- 53Morocco23.6
- 54Kenya21.4
- 55Canada21
- 56Malta19.9
- 57South Africa16.5
- 58Ukraine15.3
- 59Australia15
- 60Poland13.7
- 61Mali13.6
- 62Tunisia13.6
- 63Brunei Darussalam12.2
- 64France11.2
- 65Ireland10.5
- 66Lithuania9.4
- 67United Kingdom8
- 68Czechia7.6
- 69Thailand7.5
- 70Mozambique6.7
- 71Luxembourg4.7
- 72Belgium4.6
- 73Germany4.4
- 74Switzerland4.1
- 75Austria3.9
- 76Latvia3.8
- 77Estonia3.1
- 78Iceland2.8
- 79Netherlands2.3
- 80Sweden1.9
- 81Denmark1.9
- 82Finland1.6
- 83Namibia0
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%)